论文部分内容阅读
随着经济全球化进程的不断推进,世界经济风云变幻,全球产业结构面临新一轮的调整和升级。自上个世纪80年代以来,在经济发展、技术进步以及世界医药市场持续增长的推动下,以跨国医药巨头为主导的全球医药产业更是发生了翻天覆地的变化。跨国医药巨头为了确立各自在全球的竞争地位,实现在全球范围内进行资源配置的目的,不断掀起并购重组的浪潮,使全球医药产业的竞争格局发生新的变化。在加入WTO的今天,中国的医药企业为了自身
With the continuous progress of economic globalization, the global economic situation is changing and the global industrial structure is facing a new round of adjustment and upgrading. Since the 1980s, under the impetus of economic development, technological progress and sustained growth in the world pharmaceutical market, the global pharmaceutical industry dominated by multinational pharmaceutical giants has undergone tremendous changes. In order to establish their respective global competitive positions and achieve the goal of allocating resources globally, transnational pharmaceutical giants have been setting off a wave of mergers and acquisitions and restructuring to bring about a new change in the competitive landscape of the global pharmaceutical industry. Today in the WTO accession, China’s pharmaceutical companies for their own sake